Background WHO recommends routine use of rotavirus vaccines in all countries, particularly
in those with high mortality attributable to diarrhoeal diseases. To establish the burden of life…

Background. Rotavirus vaccine is recommended for routine use in all countries globally. To
facilitate decision making on rotavirus vaccine adoption by countries, help donors prioritize …

Rotavirus infections are a leading cause of severe, dehydrating gastroenteritis in children< 5
years of age. Despite the global introduction of vaccinations for rotavirus over a decade ago…

Background Human adenoviruses typically cause self-limited respiratory, gastrointestinal,
and conjunctival infections in healthy children. In late 2021 and early 2022, several previously …

As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have
been reported from 35 countries, including the USA 1 , 2 . Previous studies have found …

ContextReported cases of pertussis among adolescents and adults have increased since the
1980s, despite increasingly high rates of vaccination among infants and children. However…

Background The evidence base for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
is nascent. We sought to characterize SARS-CoV-2 transmission within US …

In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus vaccination
on hospitalizations and deaths from rotavirus and all-cause acute gastroenteritis (AGE) …

BACKGROUND: In 2006, routine immunization of US infants against rotavirus was initiated.
We assessed national, regional, and local trends in rotavirus testing and detection before …

Two rotavirus vaccines, Rotarix (RV1) and RotaTeq (RV5), were licensed for global use in
2006. A systematic review of 48 peer- reviewed articles with postlicensure data from 24 …